210 related articles for article (PubMed ID: 17686497)
1. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol.
Borgkvist A; Marcellino D; Fuxe K; Greengard P; Fisone G
Neuropharmacology; 2008 Jan; 54(1):31-5. PubMed ID: 17686497
[TBL] [Abstract][Full Text] [Related]
2. Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors.
Håkansson K; Galdi S; Hendrick J; Snyder G; Greengard P; Fisone G
J Neurochem; 2006 Jan; 96(2):482-8. PubMed ID: 16336634
[TBL] [Abstract][Full Text] [Related]
3. Regulation of DARPP-32 phosphorylation by three distinct dopamine D1-like receptor signaling pathways in the neostriatum.
Kuroiwa M; Bateup HS; Shuto T; Higashi H; Tanaka M; Nishi A
J Neurochem; 2008 Nov; 107(4):1014-26. PubMed ID: 18823371
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons.
Kuroiwa M; Hamada M; Hieda E; Shuto T; Sotogaku N; Flajolet M; Snyder GL; Hendrick JP; Fienberg A; Nishi A
Neuropharmacology; 2012 Dec; 63(7):1248-57. PubMed ID: 22971543
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.
Edwards S; Simmons DL; Galindo DG; Doherty JM; Scott AM; Hughes PD; Wilcox RE
Alcohol Clin Exp Res; 2002 Feb; 26(2):173-80. PubMed ID: 11964556
[TBL] [Abstract][Full Text] [Related]
6. Modifications in DARPP-32 phosphorylation pattern after repeated palatable food consumption undergo rapid habituation in the nucleus accumbens shell of non-food-deprived rats.
Danielli B; Scheggi S; Grappi S; Marchese G; De Montis MG; Tagliamonte A; Gambarana C
J Neurochem; 2010 Jan; 112(2):531-41. PubMed ID: 19895662
[TBL] [Abstract][Full Text] [Related]
7. Role of Dopamine Type 1 Receptors and Dopamine- and cAMP-Regulated Phosphoprotein Mr 32 kDa in Δ9-Tetrahydrocannabinol-Mediated Induction of ΔFosB in the Mouse Forebrain.
Lazenka MF; Tomarchio AJ; Lichtman AH; Greengard P; Flajolet M; Selley DE; Sim-Selley LJ
J Pharmacol Exp Ther; 2015 Sep; 354(3):316-27. PubMed ID: 26099530
[TBL] [Abstract][Full Text] [Related]
8. Blockade of adenosine A2A receptors downregulates DARPP-32 but increases ERK1/2 activity in striatum of dopamine deficient "weaver" mouse.
Botsakis K; Pavlou O; Poulou PD; Matsokis N; Angelatou F
Neurochem Int; 2010 Jan; 56(2):245-9. PubMed ID: 19852993
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized rats.
Scheggi S; Crociani A; De Montis MG; Tagliamonte A; Gambarana C
Neuroscience; 2009 Oct; 163(2):627-39. PubMed ID: 19559764
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of (-)-stepholidine on protein phosphorylation of a dopamine- and cAMP-regulated phosphoprotein in denervated striatum of oxidopamine-lesioned rats.
Guo X; Liu J; Zou LL; Jin J; Wang BC; Jin GZ
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):100-3. PubMed ID: 10374628
[TBL] [Abstract][Full Text] [Related]
11. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern.
Rauggi R; Scheggi S; Cassanelli A; De Montis MG; Tagliamonte A; Gambarana C
J Neurochem; 2005 Feb; 92(4):867-77. PubMed ID: 15686489
[TBL] [Abstract][Full Text] [Related]
12. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons.
Dell'anno MT; Pallottino S; Fisone G
Neuropharmacology; 2013 Mar; 66():179-86. PubMed ID: 22507666
[TBL] [Abstract][Full Text] [Related]
13. Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1.
Bonito-Oliva A; Pallottino S; Bertran-Gonzalez J; Girault JA; Valjent E; Fisone G
Neuropharmacology; 2013 Sep; 72():197-203. PubMed ID: 23643747
[TBL] [Abstract][Full Text] [Related]
14. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
Borgkvist A; Usiello A; Greengard P; Fisone G
Neuropsychopharmacology; 2007 Sep; 32(9):1995-2003. PubMed ID: 17251906
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.
Svenningsson P; Lindskog M; Ledent C; Parmentier M; Greengard P; Fredholm BB; Fisone G
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1856-60. PubMed ID: 10677546
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons.
Andersson M; Usiello A; Borgkvist A; Pozzi L; Dominguez C; Fienberg AA; Svenningsson P; Fredholm BB; Borrelli E; Greengard P; Fisone G
J Neurosci; 2005 Sep; 25(37):8432-8. PubMed ID: 16162925
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic acetylcholine M
Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
[TBL] [Abstract][Full Text] [Related]
18. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.
Verty AN; McGregor IS; Mallet PE
Brain Res; 2004 Sep; 1020(1-2):188-95. PubMed ID: 15312802
[TBL] [Abstract][Full Text] [Related]
19. Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain.
Ozaita A; Puighermanal E; Maldonado R
J Neurochem; 2007 Aug; 102(4):1105-14. PubMed ID: 17484726
[TBL] [Abstract][Full Text] [Related]
20. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons.
Bertran-Gonzalez J; Håkansson K; Borgkvist A; Irinopoulou T; Brami-Cherrier K; Usiello A; Greengard P; Hervé D; Girault JA; Valjent E; Fisone G
Neuropsychopharmacology; 2009 Jun; 34(7):1710-20. PubMed ID: 19158668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
